Shimadzu Webinar: Expanded Newborn Screening by Tandem Mass Spectrometry
14 Novembre 2017
Newborn screening (NBS) program is a complex and organized system consisting of family and personnel education, biochemical tests, confirmatory biochemical and genetic tests, diagnosis, therapy, and patient follow up. Now that tandem mass spectrometry data can provide a very accurate and fast screening results, the question is how far we can extend this technology to address a wider range of disorders, and how easily this can be implemented to clinical laboratories.
By attending the Shimadzu’s webinar you will learn…
– Statistics and historical background of NBS conducted in various countries.
– What novel NBS strategies are now available and how these can contribute to well-being of the newborns.
– Analytical aspect of NBS using tandem mass spectrometry.
Prof la Marca has expertise in clinical chemistry and is the leading pioneer in the field of newborn screening (NBS) for developing and improving new methodologies. He is also extremely keen to train and help other scientists to implement tandem mass spectrometry for NBS, and for these contributions he has been awarded the Jean Dussault Medal 2014 by International Society for Neonatal Screening.